Clinical trial
A Randomized Controlled Study of Postoperative Adjuvant Therapy of…
NCT00152191 · Taiho Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00152191 |
|---|---|
| Title | A Randomized Controlled Study of Postoperative Adjuvant Therapy of Uracil-tegafur (UFT) Compared With Cyclophosphamide/Methotrexate/5-fluorouracil (CMF) in Breast Cancer (NSAS-BC) |
| Official title | A Randomized Controlled Study of Postoperative Adjuvant Therapy of UFT Compared With CMF in High-risk Women With Axillary Node-negative Breast Cancer (NSAS-BC) |
| Lead sponsor | Taiho Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | UFT (uracil, tegafur), cyclophosphamide, methotrexate, and fluorouracil |
| Enrollment | 1,300 |
| Start date | Oct 1, 1996 |
| Primary completion | Oct 1, 2007 |
| Completion | Jan 1, 2008 |
| First posted | Sep 9, 2005 |
| Last update posted | Jul 7, 2011 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: